Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Consumer health
Fierce Healthcare
Hims & Hers partners with Eli Lilly to sell Zepbound, Foundayo
Hims & Hers struck a deal with Eli Lilly to offer the drugmaker’s branded obesity treatments through its online health and wellness platform.
Heather Landi
Nov 6, 2026 4:30pm
Haleon joins the AI deal wave with Microsoft collab
Jul 1, 2026 10:14am
Stada snaps up 16 consumer health lines from Orifarm
Jun 24, 2026 11:20am
Haleon tackles sports injuries with latest soccer play
May 13, 2026 10:34am
Daiichi Sankyo plots $1.5B consumer health unit sale to Suntory
Apr 15, 2026 3:22pm
Bayer signs Ludacris to One A Day multivitamin campaign
Mar 27, 2026 10:47am
More News
Clear prices, e-commerce experience a must for pharma DTP sites
Mar 10, 2026 12:56pm
Lilly adds multidose Zepbound pens to self-pay menu
Feb 23, 2026 9:00am
Troubled Kenvue sells itself to Kimberly-Clark in $48.7B buyout
Nov 3, 2025 11:51am
72% of consumers interested in DTC drug sales: survey
Oct 21, 2025 9:00am
See more stories